The information contained on this website is only a summary of the information presented in more detail in the Notice of Pendency. Because this website is just a summary, you should review the Notice for additional details.
Summary of the Action
The Notice is being sent pursuant to Rule 23 of the Federal Rules of Civil Procedure and an Order of the United States District Court for the District of New Jersey (the “Court”), entered November 14, 2019, certifying the above-captioned Action as a class action. The purpose of the Notice is to inform you of: (a) the pendency of the above-captioned class action in the United States District Court for the District of New Jersey (the “Action”); (b) the certification of the three Classes defined below, of which you may be a member (“Class Member”); and (c) your right to be excluded from the Classes. This Action has not been settled and continues to be litigated. Accordingly, no claim form need be filed at this time.
This Action is a securities class action lawsuit alleging violations of Sections 10(b), 14(e) and 20(a) of the Securities Exchange Act of 1934 and certain claims under Israeli law. This lawsuit asserts that Defendants made material misrepresentations and omissions regarding: (a) the performance and integration of Omega, which Perrigo acquired in early 2015; and (b) Perrigo’s pricing strategy, noncompetitive practices, and the competitive environment for Perrigo’s generic prescription drug unit. Defendants are Perrigo, Joseph Papa, Perrigo’s former Chief Executive Officer, and Judy Brown, Perrigo’s former Chief Financial Officer.
Defendants deny all claims and wrongdoing asserted in the Action and any liability arising out of the conduct alleged in the Amended Complaint.
Discovery in this Action is ongoing. The Court has not yet set a deadline for filing summary judgment motions or scheduled a trial date.
The members of the Class are:
(1) All persons who purchased Perrigo Co., plc’s (“Perrigo”) publicly traded common stock between April 21, 2015 and May 2, 2017, both dates inclusive, on the New York Stock Exchange or any other trading center within the United States and were damaged thereby; (2) All persons who purchased Perrigo’s publicly traded common stock between April 21, 2015 and May 2, 2017, both dates inclusive, on the Tel Aviv Stock Exchange and were damaged thereby; and (3) All persons who owned Perrigo common stock as of November 12, 2015 and held such stock through at least 8:00 a.m. on November 13, 2015 (whether or not a person tendered their shares in response to tender offer of Mylan, N.V.). .
|YOUR RIGHTS AS A CLASS MEMBER:
||You will be bound by all orders and judgments in this Action, whether favorable or unfavorable. If the Classes prevail on the common issues, or if a settlement is reached, you may be able to recover an award. If Defendants prevail, you may not pursue a lawsuit on your own behalf with regard to any of the issues decided in this Action. Your interests are being represented by the Class Representative and Class Counsel. You will not be personally responsible for attorneys’ fees or costs unless you hire your own individual attorney. Class Counsel has agreed to represent the Classes on a contingent fee basis, which means that it will be awarded fees and costs only if it succeeds in obtaining a recovery from one or more of the Defendants. Any attorneys’ fees and costs will be awarded by this Court from the settlement or judgment, if any, obtained on behalf of the Classes. You may remain a member of the Class(es) and elect to be represented by counsel of your own choosing. If you retain your own separate counsel, you will be responsible for that counsel’s fees and expenses, and such counsel must enter an appearance on your behalf by filing a Notice of Appearance with the Court and mailing it to Class Counsel at the address set forth below on or before December 3, 2020.
|ASK TO BE EXCLUDED
||If you choose to be excluded from the Class, you will not be bound by any judgment in this Action, nor will you be eligible to share in any recovery that might be obtained in this Action. If you choose to be excluded, or in other words, “opt-out” of the Action, you may individually pursue any legal rights that you may have against any of the Defendants. Please note that if you exclude yourself from the Class(es) and decide to pursue your own action individually, you may not be able to pursue certain claims due to the lapsing of the statute of limitations and/or statute of repose. Requests for exclusion must be mailed to the address set forth below on or before December 3, 2020.
Detailed information about the pending Lawsuit is contained in the Notice available for download on the Important Documents page on this website. Additional information can also be obtained by contacting the Notice Administrator by calling toll-free 1-833-674-0175 or emailing Info@PerrigoSecuritiesLitigation.com or mailing a letter to:
How do I obtain more information?
Perrigo Securities Litigation
c/o JND Legal Administration
PO Box 91374
Seattle, WA 98111
Inquiries should NOT be directed to the Court or the Clerk of the Court.